In Episode 1: Decoding Biosimilars – Scott Webb and Azim Bari from Gateway Health Partners along with Paul Fischer from VytlOne break down the evolving landscape of biosimilars. In this 30-minute webinar, you’ll gain expert insights on: Thanks to VytlOne for their partnership with this series.
This is the first in a series of legislative updates from Mike Strahan, Senior Vice President of Strategy at Gateway Health Partners. After more than two decades as a healthcare attorney, including time spent leading legal strategy and operations for a major PBM and helping launch Ascent Health Services, I’ve had a front-row seat to…
By A. Azim Bari, PharmD, MBA, BCPS, Chief Clinical Officer for Gateway Health Partners In the nearly two decades since their introduction to the market, there has been a steady increase in the number of glucagon-like peptide-1 (GLP-1) agonist class products. Most recently, a newer generation of GLP-1s that includes semaglutide (Ozempic, Rybelsus and Wegovy)…
Despite a slight improvement in recent months, drug shortages remain a persistent challenge across the U.S. healthcare system. As of April 2025, there were 270 active shortages, according to the American Society of Health-System Pharmacists (ASHP). More than 40% of those began in 2022 or earlier, signaling more long-term issues and not just temporary setbacks….
Written By Jen Proudfit, Executive Director of Sales and Business Development Rebate reconciliation is essential for ensuring you’re not leaving money on the table in your pharmacy rebate agreements. However, the process can sometimes become complex without clarity and a structured approach. To simplify the process, start by asking these key questions: What Claims Qualify…
Written By Jen Proudfit, Executive Director of Sales and Business Development Pharmacy rebate management can be a game-changer for managing drug costs and optimizing savings, with some rebate values for brand-name drugs exceeding 30-50% of list price. Yet, many organizations neglect to regularly review their rebate payments to ensure they align with their contract terms….
From Dispensing Medications to Transforming Healthcare Over the past few decades, as the healthcare landscape in the U.S. has become increasingly complex, the role of pharmacists has dramatically evolved. They have transformed from traditional dispensers of medications to critical players in almost every aspect of the healthcare industry. With rising chronic diseases, an aging population,…
No one likes surprises, especially when they create negative and unexpected adjustments to rebate guarantees. As we step into 2025, changes in market conditions and regulations are expected to trigger adjustments to existing guarantees. Staying informed and partnering with a trusted, transparent advisor with a client-first approach can help you navigate these shifts with clarity…
The final installment of a three-part series by Sam Warman Vice President of Client Consulting at Gateway Health Partners on understanding and optimizing medical rebates. Unlocking the Value of Medical Rebates As the number of specialty medications utilized in a healthcare setting continues to grow, so does the need for strategies to control costs and…
Part two of a three-part series by Sam Warman Vice President at Gateway Health Partners on understanding and optimizing medical rebates. Since medical rebates began, they have grown to become essential in offsetting the costs of specialty drugs administered in a clinical setting. Historically, because the use of these specialty medications falls under a patient’s…